Description
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent insulin signalling, glucagon regulation, gastric emptying and appetite-related pathways. Semaglutide has attracted significant research interest for its effects on appetite regulation, satiety, glucose metabolism and body-weight regulation. As a GLP-1 receptor agonist, studies have investigated its ability to reduce energy intake and support substantial weight loss, alongside improvements in glycaemic control and several cardiometabolic risk markers. Research has also examined cardiovascular and kidney outcomes in specific clinical populations.
Tides Semaglutide is supplied as lyophilised powder and intended exclusively for controlled laboratory and research applications. Each batch is independently tested to verify identity and purity, providing researchers with a consistent, traceable material for experimental use.
Key product information:
- Lyophilised powder
- Purity >99.8%
- Independently batch tested
- Certificate of Analysis available
- UK-dispatched
- For research use only
Important: For research use only. Not for human or veterinary use. Not intended for diagnosis, treatment, prevention or mitigation of any disease.
Reviews
There are no reviews yet.